mannitol has been researched along with griseofulvin in 18 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (5.56) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 7 (38.89) | 29.6817 |
2010's | 9 (50.00) | 24.3611 |
2020's | 1 (5.56) | 2.80 |
Authors | Studies |
---|---|
Duffy, EM; Jorgensen, WL | 1 |
Baert, B; Beetens, J; Bodé, S; De Spiegeleer, B; Deconinck, E; Lambert, J; Slegers, G; Slodicka, M; Stoppie, P; Van Gele, M; Vander Heyden, Y | 1 |
Du-Cuny, L; Mash, EA; Meuillet, EJ; Moses, S; Powis, G; Song, Z; Zhang, S | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K | 1 |
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
Barber, S; Dew, TP; Farrell, TL; Poquet, L; Williamson, G | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Loo, JC; Riegelman, S; Rowland, M | 1 |
Barale, R; Bosco, E; Frenzilli, G | 1 |
Araki, H; Hamada, S; Itoh, S; Kobayashi, K; Kubo, K; Lorenzon, G; Lorge, E; Marzin, D; Matsui, A; Matsuoka, A; Miyajima, H; Nishida, S; Senjyu, N; Thybaud, V; Wakata, A; Yamakage, K; Yamamura, E; Yoshida, J | 1 |
Awogi, T; Bichet, N; Elhajouji, A; Lorenzon, G; Lorge, E; Marzin, D; Meunier, JR; Oliver, J; Ouldelhkim, MC; Thybaud, V | 1 |
Aardema, MJ; Lorenzon, G; Lorge, E; Marzin, D; Oliver, J; Thybaud, V; Wakata, A | 1 |
Arpagaus, C; Friess, W; Schmid, K | 1 |
Azad, M; Bhakay, A; Bilgili, E; Dave, RN; Vizzotti, E | 1 |
Kann, B; Muehlenfeld, C; Thommes, M; Windbergs, M | 1 |
Hashimoto, N; Horii, S; Nakada, Y; Seko, F; Takeuchi, H; Teramoto, K; Yuminoki, K | 1 |
Abbott, A; Khadra, I; Maclean, N; Mann, J; Markl, D; Mead, H | 1 |
1 review(s) available for mannitol and griseofulvin
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
17 other study(ies) available for mannitol and griseofulvin
Article | Year |
---|---|
Prediction of drug solubility from Monte Carlo simulations.
Topics: Monte Carlo Method; Pharmaceutical Preparations; Solubility | 2000 |
Transdermal penetration behaviour of drugs: CART-clustering, QSPR and selection of model compounds.
Topics: Anti-Inflammatory Agents; Cell Membrane Permeability; Cluster Analysis; Drug Evaluation, Preclinical; Humans; Models, Biological; Predictive Value of Tests; Quantitative Structure-Activity Relationship; Regression Analysis; Skin; Skin Absorption | 2007 |
Computational modeling of novel inhibitors targeting the Akt pleckstrin homology domain.
Topics: Antineoplastic Agents; Blood Proteins; Caco-2 Cells; Cell Membrane Permeability; Computer Simulation; Drug Discovery; Drug Screening Assays, Antitumor; Humans; Models, Molecular; Phosphoproteins; Protein Binding; Protein Kinase Inhibitors; Protein Structure, Tertiary; Proto-Oncogene Proteins c-akt; Quantitative Structure-Activity Relationship | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
QSAR-based permeability model for drug-like compounds.
Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2011 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Predicting phenolic acid absorption in Caco-2 cells: a theoretical permeability model and mechanistic study.
Topics: Artificial Intelligence; Caco-2 Cells; Cell Membrane Permeability; Cinnamates; Enterocytes; Humans; Hydrophobic and Hydrophilic Interactions; Intestinal Absorption; Kinetics; Models, Biological; Molecular Conformation; Osmolar Concentration; Phenols | 2012 |
Shortcomings in pharmacokinetic analysis by conceiving the body to exhibit properties of a single compartment.
Topics: Aspirin; Griseofulvin; Humans; Injections, Intravenous; Intestinal Absorption; Kinetics; Male; Mannitol; Models, Theoretical; Penicillin G; Pentobarbital; Pharmaceutical Preparations | 1968 |
Validation of single cell gel assay in human leukocytes with 18 reference compounds.
Topics: 4-Nitroquinoline-1-oxide; Adult; Animals; Ascorbic Acid; Benzaldehydes; Benzo(a)pyrene; Biotransformation; Bleomycin; Chlorophyllides; Cyclophosphamide; DNA Damage; Epoxy Compounds; Female; Formaldehyde; Glucose; Glutaral; Griseofulvin; Humans; Hydrogen Peroxide; Hydrogen-Ion Concentration; Leukocytes; Mannitol; Methylmercury Compounds; Microsomes, Liver; Mitomycin; Mutagenicity Tests; Pyrenes; Rats; Reproducibility of Results; Sodium Azide | 2000 |
SFTG international collaborative study on in vitro micronucleus test IV. Using CHL cells.
Topics: Aneugens; Animals; Bleomycin; Cell Line; Clofibrate; Colchicine; Cricetinae; Cytarabine; Cytochalasin B; Diethylstilbestrol; Fluorouracil; Griseofulvin; In Vitro Techniques; International Cooperation; Mannitol; Micronucleus Tests; Mutagens; Urethane | 2006 |
SFTG international collaborative study on in vitro micronucleus test V. Using L5178Y cells.
Topics: Aneugens; Animals; Bleomycin; Colchicine; Fluorouracil; Griseofulvin; In Vitro Techniques; International Cooperation; Leukemia L5178; Mannitol; Mice; Micronucleus Tests; Mutagens | 2006 |
SFTG international collaborative study on in vitro micronucleus test I. General conditions and overall conclusions of the study.
Topics: Aneugens; Animals; Bleomycin; Cell Line; CHO Cells; Clofibrate; Colchicine; Cricetinae; Cytarabine; Cytochalasin B; Diethylstilbestrol; Fluorouracil; Griseofulvin; Humans; In Vitro Techniques; International Cooperation; Leukemia L5178; Lymphocytes; Mannitol; Mice; Micronucleus Tests; Mitomycin; Mutagens; Thiabendazole | 2006 |
Evaluation of the Nano Spray Dryer B-90 for pharmaceutical applications.
Topics: Aerosols; Equipment Design; Excipients; Griseofulvin; Mannitol; Microscopy, Electron, Scanning; Nanoparticles; Particle Size; Pharmaceutical Preparations; Powders; Surface Properties; Surface Tension; Technology, Pharmaceutical; Trehalose | 2011 |
Enhanced recovery and dissolution of griseofulvin nanoparticles from surfactant-free nanocomposite microparticles incorporating wet-milled swellable dispersants.
Topics: Carboxymethylcellulose Sodium; Cellulose; Griseofulvin; Mannitol; Nanocomposites; Particle Size; Sodium Dodecyl Sulfate; Solubility; Surface-Active Agents; Technology, Pharmaceutical | 2014 |
Solid dispersion prepared by continuous cogrinding in an air jet mill.
Topics: Antifungal Agents; Calorimetry, Differential Scanning; Chemistry, Pharmaceutical; Excipients; Griseofulvin; Mannitol; Particle Size; Powder Diffraction; Solubility; Spectrum Analysis, Raman; X-Ray Diffraction | 2013 |
Preparation and evaluation of high dispersion stable nanocrystal formulation of poorly water-soluble compounds by using povacoat.
Topics: Administration, Oral; Animals; Biological Availability; Cellulose; Chemistry, Pharmaceutical; Crystallization; Drug Stability; Excipients; Freeze Drying; Griseofulvin; Hydrophobic and Hydrophilic Interactions; Kinetics; Male; Mannitol; Nanoparticles; Nanotechnology; Polymethyl Methacrylate; Polyvinyl Alcohol; Povidone; Rats, Sprague-Dawley; Solubility; Technology, Pharmaceutical | 2014 |
Formulation-dependent stability mechanisms affecting dissolution performance of directly compressed griseofulvin tablets.
Topics: Griseofulvin; Lactose; Mannitol; Solubility; Tablets | 2023 |